Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIMDAMAL II
PACTR201907479787308Phase 3Not yet recruiting
- Sponsor
- Colorado State University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in malaria comparing Ivermectin mass drug administration with Placebo mass drug administration (2 arms). Primary endpoint: Malaria incidence. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201907479787308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907479787308.